LJN Newsletters

In Association for Molecular Pathology v. USPTO, the United States District Court for the Southern District of New York invalidated patents related to isolated BRCA1 and BRCA2 breast and ovarian cancer susceptibility genes. The surprising aspect of the decision was the reason for invalidity ' the district court held that the isolated genes did not constitute patentable subject matter under 35 U.S.C. ' 101.

How do you integrate your individual online efforts in a coordinated strategy to build brand awareness and achieve your marketing and business development goals?

The year 2013 will mark the first year that authors can take advantage of the Copyright Act's ' 203 termination provision, likely setting off a flood of termination notices by artists seeking to regain rights previously granted to record labels, book publishers, advertising agencies, and other content owners. This newly effective right, particularly when combined with the increasing number of works subject to termination under the Act, will soon bring to the legal forefront the complex and until now largely ignored termination provisions of the Copyright Act.

Recent rulings of interest to you and your practice.

Cutting-Edge Case Developments in Film and TV Law, New York City, May 26

Bruce Lee T-Shirt Suit Transferred to New York
Infringement Suit Against Tim McGraw Remains Dismissed
No Summary Judgment in "I'll Fly Away" Copyright Termination Suit

ARBITRATION PROVISION/FORMER BAND MEMBERS
FILM DISTRIBUTION/ADVANCE REPAYMENTS

In pharmaceutical and medical device litigation, the failure-to-warn claim continues to be among the most common causes of action. This article examines some of the key factors involved in proving causation in a failure-to-warn case, and discusses recent case law in this area.